188 related articles for article (PubMed ID: 36601065)
1.
Dai R; Zhao X; Zhuo H; Wang W; Xu Y; Hu Z; Zhang T; Zhao J
Front Cardiovasc Med; 2022; 9():1016126. PubMed ID: 36601065
[TBL] [Abstract][Full Text] [Related]
2. Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease.
Koba S; Satoh N; Ito Y; Yokota Y; Tsunoda F; Sakai K; Nakamura Y; Shoji M; Hirano T; Shinke T
Clin Chem; 2024 Jul; 70(7):957-966. PubMed ID: 38757272
[TBL] [Abstract][Full Text] [Related]
3. Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development.
Wu D; Yang Q; Su B; Hao J; Ma H; Yuan W; Gao J; Ding F; Xu Y; Wang H; Zhao J; Li B
Front Cardiovasc Med; 2021; 8():619386. PubMed ID: 33937355
[No Abstract] [Full Text] [Related]
4. Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients.
Shi Y; Yang Y; Feng M; Ling W; Wei T; Cao Y; Zhong R; Wu H
Int J Gen Med; 2023; 16():3473-3481. PubMed ID: 37601806
[TBL] [Abstract][Full Text] [Related]
5. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
[TBL] [Abstract][Full Text] [Related]
6. Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease.
Ishii J; Kashiwabara K; Ozaki Y; Takahashi H; Kitagawa F; Nishimura H; Ishii H; Iimuro S; Kawai H; Muramatsu T; Naruse H; Iwata H; Tanizawa-Motoyama S; Ito H; Watanabe E; Matsuyama Y; Fukumoto Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Hokimoto S; Miyauchi K; Ohtsu H; Izawa H; Ogawa H; Daida H; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R
J Atheroscler Thromb; 2022 Oct; 29(10):1458-1474. PubMed ID: 34880156
[TBL] [Abstract][Full Text] [Related]
7. Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease.
Sakai K; Koba S; Nakamura Y; Yokota Y; Tsunoda F; Shoji M; Itoh Y; Hamazaki Y; Kobayashi Y
Geriatr Gerontol Int; 2018 Jun; 18(6):965-972. PubMed ID: 29512264
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Small Dense Low Density Lipoprotein and Coronary Artery Disease in North Indian Patients.
Goel PK; Ashfaq F; Khanna R; Ramesh V; Pandey CM
Indian J Clin Biochem; 2017 Jun; 32(2):186-192. PubMed ID: 28428693
[TBL] [Abstract][Full Text] [Related]
9. Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein.
Juhi A; Jha K; Mondal H
Cureus; 2023 Jan; 15(1):e33924. PubMed ID: 36819362
[TBL] [Abstract][Full Text] [Related]
10. Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment.
Yamaji T; Harada T; Kajikawa M; Maruhashi T; Kishimoto S; Yusoff FM; Chayama K; Goto C; Nakashima A; Tomiyama H; Takase B; Kohro T; Suzuki T; Ishizu T; Ueda S; Yamazaki T; Furumoto T; Kario K; Inoue T; Watanabe K; Takemoto Y; Hano T; Sata M; Ishibashi Y; Node K; Maemura K; Ohya Y; Furukawa T; Ito H; Yamashina A; Koba S; Higashi Y
J Atheroscler Thromb; 2024 Apr; 31(4):478-500. PubMed ID: 37926523
[TBL] [Abstract][Full Text] [Related]
11. Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.
Huang YC; Chang PY; Hwang JS; Ning HC
Biomed J; 2014; 37(6):375-9. PubMed ID: 25179702
[TBL] [Abstract][Full Text] [Related]
12. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.
Nishikura T; Koba S; Yokota Y; Hirano T; Tsunoda F; Shoji M; Hamazaki Y; Suzuki H; Itoh Y; Katagiri T; Kobayashi Y
J Atheroscler Thromb; 2014; 21(8):755-67. PubMed ID: 24717762
[TBL] [Abstract][Full Text] [Related]
13. Development of Machine Learning Tools for Predicting Coronary Artery Disease in the Chinese Population.
Zhang T; Huang S; Xie P; Li X; Pan Y; Xu Y; Han P; Ding F; Zhao J; Tang H
Dis Markers; 2022; 2022():6030254. PubMed ID: 36438901
[TBL] [Abstract][Full Text] [Related]
14. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
[TBL] [Abstract][Full Text] [Related]
15. A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test.
Sampson M; Wolska A; Warnick R; Lucero D; Remaley AT
Clin Chem; 2021 Jul; 67(7):987-997. PubMed ID: 33876239
[TBL] [Abstract][Full Text] [Related]
16. The role of small dense LDL-C/large buoyant LDL-C ratio as an independent risk factor in patients with type 2 diabetes mellitus and metabolic syndrome.
Wang C; Li Y; Peng P; Lin H; Zhu Y; Xu X; Wu P; Zhang Y; Xu T; Ren J; Xu H; Dong G; Xu Y; Jiang H; Zhao J; Zhai Y; Zai G
Ann Biol Clin (Paris); 2024 Jun; 82(2):174-186. PubMed ID: 38832689
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
18. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study.
Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Apr; 19(1):45. PubMed ID: 32245386
[TBL] [Abstract][Full Text] [Related]
19. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Zhang J; He L
BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
